TFX vs. EW: Which Stock Is the Better Value Option?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?
TFX vs. EW: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
Is Teleflex Stock a Smart Option for Your Portfolio Right Now?
TFX instils optimism with its robust performance in the Interventional category and potential in Asia.
TFX or PEN: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks offers value investors a better bang for their buck right now?
Teleflex's (TFX) Titan SGS Stapler Showcases Positive Outcomes
Teleflex (TFX) publishes an analysis of clinical data showcasing the Titan SGS Stapler's enhanced clinical outcomes and significant efficiency benefits.
TFX or EW: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Teleflex (TFX) or Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?
TFX or EW: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
Why Teleflex (TFX) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Teleflex (TFX) Tops Q2 Earnings Estimates, Raises 2024 Outlook
Teleflex's (TFX) diversified portfolio and global footprint have driven durable growth in the second quarter of 2024.
Teleflex Incorporated (TFX) Q2 2024 Earnings Call Transcript
Teleflex Incorporated (NYSE:TFX ) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ET Company Participants Lawrence Keusch - Vice President-Investor Relations & Strategy Development Liam Kelly - Chairman, President & Chief Executive Officer Thomas Powell - Executive Vice President & Chief Financial Officer Conference Call Participants Anthony Petrone - Mizuho Group Matthew O'Brien - Piper Sandler Jayson Bedford - Raymond James Shagun Singh - RBC George Sellers - Stephens Inc Rich Newitter - Truist Mike Polark - Wolfe Craig Bijou - Bank of America Dave Turkaly - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Teleflex Second Quarter 2024 Earnings Conference Call. At this time, all participants have been placed in a listen-only mode.
Compared to Estimates, Teleflex (TFX) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Teleflex (TFX) Q2 Earnings Surpass Estimates
Teleflex (TFX) came out with quarterly earnings of $3.42 per share, beating the Zacks Consensus Estimate of $3.33 per share. This compares to earnings of $3.41 per share a year ago.
